Lineage Cell Therapeutics, Inc. Quarterly Costs and Expenses in USD from Q1 2023 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Lineage Cell Therapeutics, Inc. quarterly Costs and Expenses history and growth rate from Q1 2023 to Q3 2024.
Lineage Cell Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $7.62M, a 4.18% decline year-over-year.

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024		$7.62M	-$332K	-4.18%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024		$7.28M	-$974K	-11.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024		$8.11M	-$923K	-10.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q3 2023		$7.95M			Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023		$8.25M			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023		$9.03M			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.